samedan logo
 
 
spacer
home > advertise
ADVERTISING OPPORTUNITIES
Why Advertise with Samedan?

 

Samedan’s range of specialist titles spans the full spectrum of pharmaceutical development, from innovation to patient, and is designed to meet the broad needs of an industry built on high-quality information, communication and expertise.

With a history going back more than a decade, Samedan’s clients range from long-established industry leaders to the most recent start-ups and university spin-outs. Many clients have advertised across our entire range for years, and have come to appreciate a strong and cooperative relationship with us.

Samedan is committed to providing the perfect editorial platform for your advert. That is why our featured articles take an opinion-led, non-promotional view of the industry. This ensures that every advert enjoys maximum impact with each title’s readership of 10,000+ key decision makers.

For further information about each of our titles, follow the links below. Each of our advertising executives can be contacted at the email addresses below and will be pleased to discuss how Samedan can meet your needs.

Tel: +44 (0)20 7724 3456
Fax: +44 (0)20 7723 2632

European Pharmaceutical Contractor
Mark Barker mark@samedanltd.com

European BioPharmaceutical Review
Neil Clarke neil@samedanltd.com

International Clinical Trials
David Hirsh david@samedanltd.com

Pharmaceutical Manufacturing and Packing Sourcer
Lee Atkinson lee@samedanltd.com

Innovations in Pharmaceutical Technology
Anthony Stewart anthony@samedanltd.com

spacer

Industry Events

7th Annual Biological Production 2008

1-4 June 2008, Munich, Germany

Now in its 7th year, the event is firmly established as Europe's leading gathering of biological manufacturing, production and cGMP specialists attending year on year to learn, network and do business. For more information please visit www.biologicalproduction.com or call +44 (0)20 7202 7558.
More info >>

News and Press Releases

Azopharma Announces Plans to Implement XcelodoseTM Technology in the Production of Early Stage Clinical Trial Materials

HOLLYWOOD, Fla. – Azopharma Product Development Group, Inc. (“Azopharma”) announced today plans to implement Xcelodose technology at its formulations development facility, ApiCross Drug Delivery Technologies. Xcelodose technology is a powder micro-dosing system developed by Meridica. This technology offers a unique powder dispensing system for small-scale capsule filling and ultimately assists in conserving valuable research material as well as reducing various Preformulation activities.
More info >>

 
©2000-2007 Samedan Ltd.
About Us | Register | Login | Site Map | Terms and Conditions | Contact Us |
Add to favourites

Print this page

Send to a friend
Privacy statement